Pioneering research in Microdosing GLP-1 The AgelessRx Applied Science Team is leading the first clinical trial focused on the healthspan-enhancing potential of Microdosing GLP-1 Ongoing observational study including long-term tracking of diverse health outcomes in over 1,000 patients using a growing real-world database of patient-reported data Clinical collaborations are currently in development to expand the scope and impact of this research How it works GLP-1s bind to GLP-1 receptors beyond the brain and gut, reaching the heart, kidneys, blood vessels, and immune cells Shown to support signaling to longevity-related pathways like AMPK and mTOR, affecting key Hallmarks of Aging like oxidative stress, inflammation, DNA repair, mitochondrial function, and autophagy At low doses, may subtly restore balance to hormone signaling, reduce inflammation (immune cells), improve cognitive function, and cardiometabolic health Effects may vary based on individual biology and with factors including inflammation, weight, lifestyle, metabolic health, and health history

absorbance at 450nm in a microplate reader and referring to the standard curve
In aging research, compounds that might influence telomerase activity are studied for their effects on cellular replicative capacity and tissue aging
If an antibiotic is sitting in your stomach for three hours instead of thirty minutes, the timing of its absorption changes
PMC 3517182
Approaches such as time-restricted eating (TRE), intermittent fasting (IF), and strategic meal timing with a low-carbohydrate diet can complement the appetite-regulating effects of GLP-1 drugs while promoting better metabolic health